October 10, 2011
Chuikyo ’s Expert Subcommittee on NHI Drug Pricing Affairs will take up the question of whether an additional NHI price reduction for long-listed drugs is necessary in next year’s NHI price revision, according to Hideki Adachi, a representative of healthcare...read more